STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
21
Codes C/M, not in net · no price filed
What the filings say about SXI
Insiders, 180 days
-$5.2M net sold
1 buyer · 5 sellers · 33% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$5.0M
6 notices
Standex International insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, STANDEX INTERNATIONAL CORP/DE/ insiders sold a net $5.2M of stock across 274 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Feb 17, 2026.
The trade is 4.7% of the 84,973 shares held after it.
3 other insiders sold within 30 days.
Insider activity: President/CEO/Chairman Dunbar David A. sold about $1.2M of SXI under a 10b5-1 plan on Aug 31, 2026; 3 other insiders sold within 30 days.
274 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SXI planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
CHORMAN THOMAS E
Filed 2026-10-01
$13.6K
CHORMAN THOMAS E
Filed 2026-09-01
$14.2K
Dunbar David A.
Filed 2026-08-31
$3.9M
GLASS ALAN J
Filed 2026-08-24
$421.8K
Sarcevic Ademir
Filed 2026-08-24
$704.1K
Executive pay vs shareholder return · David Dunbar
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$6.4M
$16.0M
$1.2M
+292%
+112%
2024
$5.1M
$3.8M
$1.1M
+185%
+140%
2023
$5.0M
$7.0M
$1.3M
+191%
+113%
2022
$5.1M
$13.9M
$1.1M
+154%
+83%
2021
$5.1M
$5.0M
$1.2M
+51%
+42%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $5.2M sold by insiders over 180 days, $5.0M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt SXI
FY Jun 2026
0.17x
FY Jun 2025
0.13x
FY Jun 2024
0.62x
FY Jun 2023
0.52x
FY Jun 2022
0.44x
Jun 2026
0.17x
Mar 2026
0.17x
Dec 2025
0.15x
Sep 2025
0.13x
Jun 2025
0.13x
Mar 2025
0.11x
Dec 2024
0.15x
Sep 2024
0.63x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+14.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity SXI
FY Jun 2026
+14.3%
FY Jun 2025
+8.7%
FY Jun 2024
+11.9%
FY Jun 2023
+25.1%
FY Jun 2022
+12.2%
Jun 2026
+14.3%
Mar 2026
+14.0%
Dec 2025
+8.2%
Sep 2025
+8.0%
Jun 2025
+8.7%
Mar 2025
+9.3%
Dec 2024
+8.5%
Sep 2024
+11.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+6.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets SXI
FY Jun 2026
+6.6%
FY Jun 2025
+4.5%
FY Jun 2024
+7.2%
FY Jun 2023
+14.2%
FY Jun 2022
+6.5%
Jun 2026
+6.6%
Mar 2026
+6.5%
Dec 2025
+3.7%
Sep 2025
+4.2%
Jun 2025
+4.5%
Mar 2025
+4.8%
Dec 2024
+4.4%
Sep 2024
+7.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+13.8%
operating income after a 21.0% effective tax rate, over long-term debt only, 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital SXI
FY Jun 2026
+13.8%
FY Jun 2025
+7.2%
FY Jun 2024
+13.4%
FY Jun 2023
+25.2%
FY Jun 2022
+12.0%
Jun 2026
+13.8%
Mar 2026
+13.5%
Dec 2025
+9.3%
Sep 2025
+7.5%
Jun 2025
+7.2%
Mar 2025
+7.0%
Dec 2024
+6.1%
Sep 2024
+12.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+14.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed SXI
FY Jun 2026
+14.0%
FY Jun 2025
+8.2%
FY Jun 2024
+11.6%
FY Jun 2023
+20.5%
FY Jun 2022
+11.0%
Jun 2026
+14.0%
Mar 2026
+13.7%
Dec 2025
+9.3%
Sep 2025
+8.6%
Jun 2025
+8.2%
Mar 2025
+7.5%
Dec 2024
+7.3%
Sep 2024
+11.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
27.93x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing SXI
FY Jun 2026
41.30x
FY Jun 2025
33.72x
FY Jun 2024
26.25x
FY Jun 2023
12.20x
FY Jun 2022
17.06x
Jun 2026
41.30x
Mar 2026
31.08x
Dec 2025
48.72x
Sep 2025
48.60x
Jun 2025
33.72x
Mar 2025
31.96x
Dec 2024
40.92x
Sep 2024
30.01x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$3.3B
market value at close 2026-10-26 on 2026-08-07 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value SXI
FY Jun 2026
$4.7B
FY Jun 2025
$2.3B
FY Jun 2024
$1.9B
FY Jun 2023
$1.7B
FY Jun 2022
$1.1B
Jun 2026
$4.7B
Mar 2026
$3.5B
Dec 2025
$3.1B
Sep 2025
$3.0B
Jun 2025
$2.3B
Mar 2025
$2.4B
Dec 2024
$2.7B
Sep 2024
$2.2B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield SXI
FY Jun 2026
+1.5%
FY Jun 2025
+2.2%
FY Jun 2024
+3.8%
FY Jun 2023
+4.0%
FY Jun 2022
+5.3%
Jun 2026
+1.5%
Mar 2026
+1.8%
Dec 2025
+2.0%
Sep 2025
+1.6%
Jun 2025
+2.2%
Mar 2025
+2.0%
Dec 2024
+2.4%
Sep 2024
+3.3%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.32x
P/E over trailing EPS growth of 87%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing SXI
FY Jun 2026
0.48x
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
0.09x
FY Jun 2022
0.25x
Jun 2026
0.48x
Mar 2026
0.50x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SXI ranks highest on growth (73rd percentile) and risk and compliance (73rd), and lowest on financial health (32nd), among Industrials peers.
Profitability
65
Inputs
Return on equity+14.3% · 64 pct, sector of 198
Return on assets+6.6% · 67 pct, sector of 224
Return on invested capital+13.8% · 57 pct, sector of 107
Return on capital employed+14.0% · 73 pct, sector of 195
Financial health
32
Inputs
Debt to equity0.69x · 30 pct, sector of 214
Cash flow to debt0.17x · 34 pct, sector of 173
Growth
73
Inputs
Revenue growth, YoY+12.8% · 73 pct, sector of 254
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
55
Inputs
Net Form 4 buying (codes P and S), 180d-$1.4M · 47 pct, sector of 170
Insider buyers, 180d1 · 63 pct, sector of 172
Risk and compliance
73
Inputs
Short interest, % of float+5.7% · 37 pct, sector of 269
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 191
New text in Risk Factors, latest 10-K+5.8% · 83 pct, sector of 197
2 not measured: Institutional and government, US patents
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SXI filings, in plain words
Are Standex International insiders buying or selling SXI?
In the 180 days to 2026-10-27, Standex International insiders were net sellers, a net $5.2M: $12.3K of purchases and $5.2M of sales reported on Form 4, by 1 buyer and 5 sellers.
Are there planned insider sales of SXI?
Yes. 6 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $5.0M of stock; the latest, by CHORMAN THOMAS E, was filed 2026-10-01.
Read the full summary
In the 180 days to 2026-10-27, Standex International insiders were net sellers of SXI, a net $5.2M across purchases and sales reported on Form 4 by 1 buyer and 5 sellers. Sales outweighed purchases more than tenfold by value. 33% of the 12 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 6 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $5.0M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.